Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands

Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands

Abstract Background Procalcitonin (PCT) testing can help in safely reducing antibiotic treatment duration in intensive care patients with sepsis. However, the cost-effectiveness of such PCT guidance is not yet known. Methods A trial-based analysis was performed to estimate the cost-effectiveness of...

Full description

Bibliographic Details
Main Authors: Michelle M. A. Kip, Jos A. van Oers, Arezoo Shajiei, Albertus Beishuizen, A. M. Sofie Berghuis, Armand R. Girbes, Evelien de Jong, Dylan W. de Lange, Maarten W. N. Nijsten, Maarten J. IJzerman, Hendrik Koffijberg, Ron Kusters
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Critical Care
Subjects:
Cost-effectiveness
Intensive care
Procalcitonin
Sepsis
Online Access:http://link.springer.com/article/10.1186/s13054-018-2234-3

Internet

http://link.springer.com/article/10.1186/s13054-018-2234-3

Similar Items